Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by 272 Capital LP

272 Capital LP decreased its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 39.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 677,940 shares of the company’s stock after selling 436,140 shares during the period. Definitive Healthcare comprises approximately 2.6% of 272 Capital LP’s investment portfolio, making the stock its 15th largest holding. 272 Capital LP owned approximately 0.59% of Definitive Healthcare worth $2,786,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD lifted its position in shares of Definitive Healthcare by 20.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company’s stock valued at $85,000 after acquiring an additional 3,496 shares in the last quarter. Principal Financial Group Inc. raised its stake in Definitive Healthcare by 9.7% in the 4th quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock valued at $181,000 after purchasing an additional 3,874 shares during the last quarter. Rhumbline Advisers lifted its holdings in Definitive Healthcare by 5.2% in the 4th quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock valued at $334,000 after purchasing an additional 4,034 shares in the last quarter. Canada Pension Plan Investment Board lifted its holdings in Definitive Healthcare by 18.1% in the 4th quarter. Canada Pension Plan Investment Board now owns 29,300 shares of the company’s stock valued at $120,000 after purchasing an additional 4,500 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in Definitive Healthcare by 27.4% during the 4th quarter. Wells Fargo & Company MN now owns 31,297 shares of the company’s stock worth $129,000 after purchasing an additional 6,736 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Trading Up 1.1 %

Shares of Definitive Healthcare stock opened at $2.75 on Friday. The stock has a 50 day moving average of $2.83 and a 200 day moving average of $3.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a market capitalization of $296.90 million, a price-to-earnings ratio of -0.89, a PEG ratio of 4.06 and a beta of 1.48. Definitive Healthcare Corp. has a fifty-two week low of $2.15 and a fifty-two week high of $7.47.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). The business had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. As a group, research analysts predict that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. The Goldman Sachs Group decreased their price target on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Barclays decreased their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday, March 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Definitive Healthcare has a consensus rating of “Hold” and a consensus target price of $5.35.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.